Back to results
US 11,883,385 B2Granted
Use of a phosphodiesterase 10 inhibitor for the treatment of tourette syndrome
AssigneeNoema Pharma AG
InventorGeorge Garibaldi
Life of this patent
Estimating the term…
Abstract
Provided herein are methods of treating Tourette Syndrome in a subject in need thereof by administering to the subject compositions comprising a PDE10 inhibitor. Also disclosed are crystalline solid forms of the compound of Formula I and uses thereof:
Claims25
A method of treating Tourette Syndrome, comprising administering to a subject in need thereof a composition comprising a therapeutically effective amount of a first therapeutic agent, wherein the therapeutic agent is a compound of Formula I:
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.